Advertisement

Topics

[News] Apalutamide shows efficacy in prostate cancer

00:44 EST 16 Feb 2018 | The Lancet

The androgen receptor inhibitor apalutamide significantly improves metastasis-free survival in patients with non-metastatic castration-resistant prostate cancer, according to a recent study.

Original Article: [News] Apalutamide shows efficacy in prostate cancer

NEXT ARTICLE

More From BioPortfolio on "[News] Apalutamide shows efficacy in prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...